Attention Costco shoppers: 5 money saving tips and tricks that everyone should know, according to experts
Nichole Schaubroeck and Tina Chow are two Canadian content creators who have each earned hundreds of thousands of followers by sharing the ins and outs of saving money while you shop.
'It's very hard to find a good deal, so anyway we can save, maybe it's not as extreme as it used to be, it's still good," said Schaubroeck who runs the account Coupon Cutie, in an interview with Yahoo Canada.
Keep reading to learn Chow and Schaubroeck's best tips and trips on how to navigate Costco like a pro.
According to Schaubroeck, Costco's price tags are a good predictor of whether or not an item will go on sale. Items that end in .97 are likely at their lowest price, making it prime time to stock up on what you need.
Another hidden hack is to look for what Costco shoppers call the 'death star,' an asterisk located in the upper right-hand corner of an item's tag.
'All this is telling you is that this item is either no longer going to be at Costco or it won't be back until next year,' said Schaubroeck.
Chow, who created the account Costco Lovers Canada, said that although the foot traffic in the store is constantly changing, sales seem to follow a schedule.
'I know that most sales end on a Sunday... new sales will begin the following week,' said Chow.
There's also what people refer to online as "Markdown Mondays" — when new items go on sale. While this is not a Costco-official event, it still creates a buzz for shoppers to find cost-friendly deals. 'They [Costco] are always doing markdowns," she added.
Additionally, Chow noted that Costco is known for 'following the trends of what's happening in the market,' which can help attract shoppers who are looking for products for a certain occasion. For example, it's not uncommon for Costco to have a sale on hamburger buns, ketchup, mustard and relish ahead of a long weekend.
Chow also recommends shopping as the weather changes to take advantage of out-of-season products at lower prices.
According to Costco customer service, shoppers are entitled to 'risk-free, 100 per cent satisfaction guarantee', meaning that the majority of purchased products can be returned and refunded at any time (excluding electronics and diamond jewelry). This allows shoppers to test out products and see if it is the right fit for them.
'If I'm going out and trying a $700 Dyson [hair dryer]... I want to be able to know that I can return it,' said Chow. 'I will always go to Costco and pay more on a product for their return policy.'
Costco also honours price adjustments on merchandise if the price drops within 30 days of the original purchase and the product is still in the store's warehouse.
Schaubroeck added that this flexibility is a large reason as to why Canadians turn to Costco for their shopping.
'It's always nice to have that reassurance when buying something, that no matter what happens, they will take it back for you,' she said.
One perk to owning a Costco membership is that it can be used worldwide at any location, which can come in handy when going on vacation.
Chow said she often uses her membership when travelling to help save on food and snacks. It's even handy for shopping and saving on souvenirs and local food.
Many Costco shoppers may not know that there's an official Costco app meant to enhance shopping experiences. The Costco app allows you to shop and save using online-only prices, check warehouse inventory and local gasoline prices, refill prescriptions at Costco's pharmacy, create your own shopping list in-app and more.
The app also allows shoppers to receive updates on sales promotions and product entering the store, a perk that Chow said is a 'huge secret' amongst Canadians.
'There are app-exclusive savings,' she said. 'If you follow Costco on Instagram, there are also exclusive savings available there."
Schaubroeck also highlights another app called Checkout 51, a platform that displays cash-back offers on Costco merchandise. While this does not apply to all products, Schaubroeck said it's an incentive worth checking out.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Bioavailability Enhancement Technologies and Services Market Industry Trends and Global Forecasts to 2035: Bioavailability Sector Set to Reach USD 10.22 Billion by 2035
The global bioavailability enhancement technologies and services market is projected to grow from USD 3.2 billion in 2025 to USD 10.22 billion by 2035, with a CAGR of 11.11%. Driven by increasing demand for drug solubility solutions, the industry sees significant growth prospects, with North America leading the market. Demand for Bioavailability Enhancement List of Bioavailability Enhancement Service Providers Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability Enhancement Technologies and Services Market Industry Trends and Global Forecasts to 2035" report has been added to offering. The global bioavailability enhancement technologies and services market is estimated to grow from USD 3.2 billion in 2025, to USD 10.22 billion by 2035, at a CAGR of 11.11% during the forecast period, to 2035. Bioavailability Enhancement Technologies and Services Market: Growth and Trends In recent years, the focus of drug developers has shifted towards development of lipophilic drug compounds due to the increasing issues with aqueous solubility of drugs. According to a recent study, around 90% of NCEs belong to BCS class II and IV, which are known to be associated with low permeability. Given that a large number of drugs fail to reach the market due to poor bioavailability, the industry is looking for various tools / methods to mitigate this challenge. Moreover, as many companies seek to re-formulate existing product candidates that exhibit poor bioavailability, the demand for novel bioavailability enhancement methods has grown significantly. It is worth mentioning that since 2000, more than 55 players offering bioavailability enhancement technologies and services have been established. Amidst the growing competition, the availability of cutting-edge tools and technologies has emerged as a differentiating factor. This has led many service / technology providers to actively expand their portfolios, either through strategic acquisitions / mergers or entering into service alliances with other bioavailability enhancement companies. As drug developers continue to evaluate novel drug targets and classes, the bioavailability enhancement domain is expected to grow at a steady pace over the next decade. Bioavailability Enhancement Technologies and Services Market: Key Insights The report delves into the current state of the bioavailability enhancement technologies and services market and identifies potential growth opportunities within the industry. Some key findings from the report include: Outsourcing has emerged as a popular model for improving drug bioavailability, with nearly 115 companies offering a wide range of services based on different bioavailability enhancement principles. At present, more than 80% of the players are offering bioavailability enhancement services focused on improving the drug solubility, primarily by adopting the solid dispersion approach. Advances in bioavailability enhancement technologies have enabled the development of novel formulations with improved pharmacokinetic properties, resulting in lucrative business opportunities for technology providers. Over 50% of the technologies are focused on enhancing the bioavailability of small molecules, specifically those intended for delivery via the oral route. A rise in partnerships focused on bioavailability enhancement services and technology platforms validates the growing interest in this domain; ~40% of such deals were instances of mergers and acquisitions. In the past decade, several clinical trials have been registered for evaluating novel therapeutic interventions with improved bioavailability, across different geographical regions. 5,800+ articles discussing various bioavailability enhancement techniques have been published in different scientific journals, thereby indicating the rapid pace of research activity within this domain. Bioavailability enhancement domain is characterized by extensive R&D activity, leading to the development of multiple high value technologies and a strong intellectual property portfolio. With the market evolving at a steady pace, emerging players need to incorporate innovative bioavailability enhancement technologies to augment their service portfolio and surpass the competition. Considering the concerns related to low solubility / permeability of certain marketed drugs and a large number of NCEs, the demand for bioavailability enhancement technologies and services is anticipated to rise in the future. Driven by the increase in number of BCS II and BCS IV molecules being evaluated in early phases of development, the bioavailability enhancement domain is likely to grow at CAGR of ~11%, till 2035. Bioavailability Enhancement Technologies and Services Market: Key Segments New Drug Approvals Occupy the Largest Share of the Bioavailability Enhancement Technologies and Services Market BCS II Drug Class is Likely to Dominate the Bioavailability Enhancement Technologies and Services Market During the Forecast Period Size Reduction Approach is the Fastest Growing Segment of the Bioavailability Enhancement Technologies and Services Market During the Forecast Period Liquid Dosage Form is Likely to Dominate the Bioavailability Enhancement Technologies and Services Market Bioavailability Enhancement Technologies and Services Market: Research Coverage Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the bioavailability enhancement technologies and services market, focusing on key market segments, including type of drug class, type of BCS classification, type of bioavailability enhancement approach, type of dosage form, and key geographical regions. Market Landscape 1: A comprehensive evaluation of bioavailability enhancement service providers, considering various parameters, such as year of establishment, company size, location of headquarters, bioavailability enhancement principle supported, bioavailability enhancement approach employed, type of dosage form supported, and route of administration of drug product. Market Landscape 2: A comprehensive evaluation of bioavailability enhancement technology providers, considering various parameters, such as year of establishment, company size, location of headquarters, bioavailability enhancement principle supported, bioavailability enhancement approach employed, type of molecule, type of dosage form supported, route of administration, availability for license and associated intellectual property rights. Key Insights: A detailed analysis, encompassing the contemporary market trends, using six schematic representations, including a world map representation depicting the region-wise distribution of various stakeholders engaged in offering bioavailability enhancement services, on the basis of their company size, a waffle chart representation, highlighting the regional distribution of bioavailability enhancement service providers, based on various types of bioavailability enhancement approaches employed by them, a heat map representation of bioavailability enhancement service providers, based on bioavailability enhancement approaches and type of dosage form, a horizontally grouped bar chart, highlighting the distribution of bioavailability enhancement service providers based on their company size and type of bioavailability enhancement principles, an insightful tree map representation of bioavailability enhancement service providers, as well as a 3D bubble analysis comparing the key players engaged in drug bioavailability enhancement market, based on several relevant parameters. Company Profiles: In-depth profiles of key industry players offering bioavailability enhancement technologies and services, focusing on company overviews, financial information, bioavailability enhancement services portfolio, recent developments and an informed future outlook. Competitive Benchmarking Analysis: A competitive benchmarking analysis that emphasizes the primary focus areas of various players engaged in the drug bioavailability enhancement market. This analysis compares their existing capabilities within and beyond their respective peer groups based in North America, Europe, Asia-Pacific, and other regions. It offers stakeholders insights into potential strategies for achieving a competitive edge in the industry. Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2013, covering mergers and acquisitions, licensing agreements, alliances, product development and manufacturing agreements, research and development agreements, product development and commercialization agreements, service agreements, and other agreements. Publication Analysis: A detailed review of peer-reviewed, scientific articles related to research on bioavailability enhancement of drug compounds and / or drug candidates, based on parameters, such as year of publication, type of publication, popular keywords, top journals, top publishers and top copyright holders. Patent Analysis: Detailed analysis of various patents filed / granted related to bioavailability enhancement approaches and technologies based on type of patent, patent application year, patent publication year, bioavailability enhancement approach, CPC symbols, geography, emerging focus area, type of organization, leading industry and non-industry players, and individual patent assignees. It also includes a patent benchmarking analysis and a detailed valuation analysis. Clinical Trial Analysis: Examination of completed, ongoing, and planned clinical studies of various bioavailability enhancement of various drug compounds and / or candidates based on parameters like trial registration year, trial phase, current recruitment status, enrolled patient population, study design, type of sponsor / collaborator, leading industry and non-industry players, type of molecule and key geographies. Technology Evaluation Framework: An insightful framework evaluating the bioavailability enhancement approaches based on various parameters, such as number of technologies, number of approved drugs, trends highlighted in published literature and patents, and business models adopted by industry stakeholders. It also provides a value addition matrix for respective bioavailability enhancement approaches currently employed by stakeholders. Players in the Bioavailability Enhancement Technologies and Services Market Profiled in the Report, Include: Adare Pharma Solutions Ascendia Pharmaceuticals Catalent Lonza Lubrizol Life Science Health Pace Life Sciences Quotient Sciences WuXi STA Reasons to Buy this Report The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants. Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies. The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects. Additional Benefits Complimentary PPT Insights Packs Complimentary Excel Data Packs for all Analytical Modules in the Report 10% Free Content Customization Detailed Report Walkthrough Session with Research Team For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachments Demand for Bioavailability Enhancement List of Bioavailability Enhancement Service Providers CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Bloomberg
9 minutes ago
- Bloomberg
Stock Movers: Ryanair, Stellantis, Convivio
On this episode of Stock Movers: - Ryanair Holdings Plc net income in the first quarter more than doubled, and the budget airline said it will recover most of the fare drop suffered last year. The stock jumped almost 10% at the open, its biggest gain in almost a month. Before today, shares of the carrier were already up 21% this year, while low-cost rivals EasyJet Plc and Wizz Air Holdings have dropped 11% and 27%, respectively. - Stellantis NV swung to a €2.3 billion ($2.7 billion) net loss in the first half as restructuring expenses, waning sales and the impact of US tariffs hit the struggling automaker. Car shipments fell 6% in the second quarter amid declines in North America and Europe. Stellantis shares fell 3.8% in Milan. The stock is down around 39% this year. - Covivio shares rise as much as 3.5%, the most in over three months, after the real estate investment trust raised its earnings outlook for the year. Analysts at Citi said the update supports its buy rating on the stock.


Bloomberg
13 minutes ago
- Bloomberg
Odd Lots: The NYC Landlords Most Worried About Zohran Mamdani
Probably the most controversial proposal from New York City Democratic mayoral nominee Zohran Mamdani is his promise to freeze the rent on a substantial chunk of rent-stabilized units in the city. There are concerns that this will cause a major downshift in housing development and that landlords that are heavily exposed to rent-stabilized units will be driven deeper into distress. But then separately there are major real estate owners who may be threatened by other aspects of Mamdani's real estate vision. For example, he has promised to, in some instances, expedite approvals for new buildings, which could take away the competitive edge from major building owners that know best how to work the approval process. But there are also players in the real estate industry who are excited about new opportunities. If housing production does, in fact, slow down, that could mean higher rent on market-rate units. And if Mamdani significantly expands the supply of free childcare in the city, then that could present an opportunity for some owners of commercial real estate. On this episode of the podcast, we speak with past guest Ben Carlos Thypin, a NYC landlord himself, as well as the founder of the analytics firm Quantierra. He gives us the overall lay of the land on how various players in the real estate industry are preparing for Mamdani's possible victory.